US Fentanyl Deaths Decline: Real Change or Temporary Pause?

Published on March 13, 2026 | Translated from Spanish

Statistics show a 34% reduction in fentanyl overdose deaths in the United States between 2023 and 2024. Analyses indicate that the main cause is lower purity of the drug in the illegal market, as it is cut with other substances. This pattern is widespread, pointing to a change in the narcotic's composition rather than public policies. Meanwhile, deaths from cocaine without opioids are rising.

Bar chart: one falls (fentanyl) and another rises (cocaine). Background with bags of adulterated drugs.

The chemical downgrade: adulteration as an unexpected variable 📉

The reduction in potency acts as an inverse quality control in the supply chain. Traffickers, by diluting fentanyl with adulterants like xylazine or caffeine, decrease the risk of lethal doses by mistake. This phenomenon is analyzed with forensic and toxicology data, creating a model where the product's impurity, not its scarcity, generates the observed effect. It is a technical change in production, not in demand.

The narcos aim for corporate social responsibility 🏢

Ironically, illegal suppliers have implemented what no state program has achieved: reducing mortality. Their risk management by lowering purity seems like a macabre calculation to keep customers alive and consuming. It's as if they had read a sustainability manual: A dead customer doesn't repeat purchase. Perhaps they expect a quality certification... for making their product less lethal.